An intervention for VA patients with congestive heart failure

American Journal of Managed Care

Volumn 16, Issue 3, 2010, Pages 158-165

  Copeland, Laurel A ^a,b   Berg, Gregory D ^c   Johnson, Donna M ^c   Bauer, Richard L ^a,b  

^a SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

^b Mays Cancer Center at UT Health San Antonio   (United States)

^c McKesson   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARDIAC GLYCOSIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BODY WEIGHT; CARDIAC PATIENT; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG COST; EXERCISE; FEMALE; FOLLOW UP; HEALTH CARE COST; HISPANIC; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PATIENT CARE; PATIENT COMPLIANCE; PATIENT MONITORING; PATIENT SATISFACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; TELECONSULTATION; THERAPY EFFECT; TREATMENT OUTCOME; VETERAN;

AGED; AGED, 80 AND OVER; COST OF ILLNESS; FEMALE; HEALTH STATUS; HEART FAILURE; HOSPITALS, VETERANS; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PATIENT SATISFACTION; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; SELF CARE; TELEMEDICINE; TELEPHONE; TREATMENT OUTCOME; UNITED STATES;

EID: 77950654992     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Spaeder J, Najjar SS, Gerstenblith G, et al. Rapid titration of Carvedilol in patients with congestive heart failure: a randomized trial of automated telemedicine versus frequent outpatient clinic visits. Am Heart J. 2006;151(4):844.e1-844.e10.
2. Jerant AF, Azan R, Martinez C, Nesbitt TS. A randomized trial of telenursing to reduce hospitalization for heart failure: patient-centered outcomes and nursing indicators. Home Health Care Serv Q. 2003;22(1):1-20.
3. Galbreath AD, Krasuski RA, Smith B, et al. Long-term healthcare and cost outcomes of disease management in a large, randomized, community-based population with heart failure [published corrections appear in Circulation. 2004;110(23):3615 and Circulation. 2006;113(3):e48]. Circulation. 2004;110(23):3518-3526.
4. Hopp F, Woodbridge P, Subramanian U, Copeland L, Smith D, Lowery J. Outcomes associated with a home care telehealth intervention, Telemed J E Health. 2006;12(3):297-307. (Pubitemid 43993730)
5. Maric B, Kaan A, Ignaszewski A, Lear SA. A systematic review of telemonitoring technologies in heart failure. Eur J Heart Fail. 2009;11(5):506-517.
6. Chin MH, Goldman L. Correlates of early hospital readmission or death in patients with congestive heart failure. Am J Cardiol. 1997;79(12):1640-1644. (Pubitemid 27339474)
7. Hunt SA, Abraham WT, Chin MH, et al; American College of Cardiology, American Heart Association Task Force on Practice Guidelines, American College of Chest Physicians, International Society for Heart and Lung Transplantation, Heart Rhythm Society. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation. 2005;112(12):e154-e235.
8. Varani E, Casella G, Magnani G, Prati F, Magelli C, Magnani B. The clinical evaluation of the severity of chronic heart failure: a comparison between the NYHA functional class and the Goldman scale [in Italian]. Cardiologia. 1990;35(8):651-656.
9. Anderson GF, Steinberg EP. Predicting hospital readmissions in the Medicare population. Inquiry. 1985;22(3):251-258.
10. Likoff MJ, Chandler SL, Kay HR. Clinical determinants of mortality in chronic congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy. Am J Cardiol. 1987;59(6):634-638.
11. Schoeller R, Andresen D, Büttner P, Oezcelik K, Vey G, Schröder R. First- or second-degree atrioventricular block as a risk factor in idiopathic dilated cardiomyopathy. Am J Cardiol. 1993;71(8):720-726. (Pubitemid 23085825)
12. Harjai KJ, Thompson HW, Turgut T, Shah M. Simple clinical variables are markers of the propensity for readmission in patients hospitalized with heart failure. Am J Cardiol. 2001;87(2):234-237, A9. (Pubitemid 32057244)
13. Krumholz HM, Chen YT, Wang Y, Radford MJ, Horwitz RI. Predictors of readmission among elderly survivors of admission with heart failure. Am Heart J. 2000;139(1, pt 1):72-77. (Pubitemid 30043627)
14. Jiang W, Alexander J, Christopher E, et al. Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Arch Intern Med. 2001;161(15):1849-1856. (Pubitemid 32762729)
15. Michalsen A, König G. Thimme W. Preventable causative factors leading to hospital admission with decompensated heart failure. Heart. 1998;80(5):437-441. (Pubitemid 28535528)
16. Hunt SA; American College of Cardiology, American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure) [published correction appears in J Am Coll Cardiol. 2006;47(7):1503-1505]. J Am Coll Cardiol. 2005;46:1116-1143.
17. Miller WR, Rollnick S. Motivational Interviewing: Preparing People to Change Addictive Behavior. New York, NY: Guilford; 1991.
18. Charlson ME, Pompei P, Ales KL, Mackenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-383.
19. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613-619.
20. Lefante JJ Jr, Harmon GN, Ashby KM, Barnard D, Webber LS. Use of the SF-8 to assess health-related quality of life for a chronically ill, low-income population participating in the Central Louisiana Medication Access Program (CMAP). Qual Life Res. 2005;14(3):665-673. (Pubitemid 40576853)
21. Ware JE, Kosinski M, Dewey JE, Gandek B. How to Score and Interpret Single-Item Health Status Measures: A Manual for Users of the SF-8 Health Survey. Lincoln, RI: Quality Metric Incorporated; 2001.
22. Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effect. Biometrika. 1983;70:41-55.
23. Weitzen S, Lapane KL, Toledano AY, Hume AL, Mor V. Principles for modeling propensity scores in medical research: a systematic literature review. Pharmacoepidemiol Drug Saf. 2004;13(12):841-853. (Pubitemid 40003819)
24. Shah BR, Laupacis A, Hux JE, Austin PC. Propensity score methods gave similar results to traditional regression modeling in observational studies: a systematic review. J Clin Epidemiol. 2005;58(6):550-559. ■ (Pubitemid 40692720)